Japan will receive all the COVID-19 vaccines it has purchased for this year from Pfizer and BioNTech, the latter firm’s head said Tuesday amid worries that delivery schedules may be disrupted by global wrangling over supplies.
Taro Kono, Japan’s vaccine czar said last week that export controls imposed by the European Union, where some vaccines are made, could delay the nation’s inoculation effort.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.